» Articles » PMID: 8835879

Sequential Changes of Tau-site-specific Phosphorylation During Development of Paired Helical Filaments

Overview
Journal Dementia
Specialty Neurology
Date 1996 Jul 1
PMID 8835879
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

It has been reported that many tau sites in neurofibrillary tangles (NFT) are abnormally phosphorylated. We investigated the phosphorylation of tau in the hippocampus of nondemented patients and Alzheimer's disease patients by immunostaining with five site-specific antibodies against phosphorylated tau. In the pretangle stage, tau in neuropil threads was phosphorylated at serines 199, 202 and 409, numbered according to the longest human tau isoform, whereas tau in some neuronal soma was phosphorylated at serines 199, 202, 409 and 422. Tau at the stage of NFT was phosphorylated at serine 396 and threonine 231 in addition to serines 199, 202, 409 and 422. In the advanced stage, tau in ghost tangles was phosphorylated mainly at serine 396. These results suggest that the phosphorylation of each site in tau differs among the maturing stages of neurofibrillary change and that abnormal phosphorylation of tau in the neuronal soma occurs at 199, 202, 409 and 422 earlier than at threonine 231 and serine 396.

Citing Articles

A novel monoclonal antibody generated by immunization with granular tau oligomers binds to tau aggregates at 423-430 amino acid sequence.

Soeda Y, Hayashi E, Nakatani N, Ishigaki S, Takaichi Y, Tachibana T Sci Rep. 2024; 14(1):16391.

PMID: 39060263 PMC: 11282240. DOI: 10.1038/s41598-024-65949-7.


Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy.

Zheng Q, Wang X Protein Cell. 2024; 16(2):83-120.

PMID: 38733347 PMC: 11786724. DOI: 10.1093/procel/pwae026.


Palmitic Acid Induces Posttranslational Modifications of Tau Protein in Alzheimer's Disease-Related Epitopes and Increases Intraneuronal Tau Levels.

Garcia-Cruz V, Arias C Mol Neurobiol. 2024; 61(8):5129-5141.

PMID: 38167971 PMC: 11249523. DOI: 10.1007/s12035-023-03886-8.


Antisense oligonucleotide-based targeting of Tau-tubulin kinase 1 prevents hippocampal accumulation of phosphorylated tau in PS19 tauopathy mice.

Yukawa K, Yamamoto-Mcguire S, Cafaro L, Hong C, Kamme F, Ikezu T Acta Neuropathol Commun. 2023; 11(1):166.

PMID: 37853497 PMC: 10585748. DOI: 10.1186/s40478-023-01661-3.


Behavioral and neuropathological characterization over the adult lifespan of the human tau knock-in mouse.

Benskey M, Panoushek S, Saito T, Saido T, Grabinski T, Kanaan N Front Aging Neurosci. 2023; 15:1265151.

PMID: 37842124 PMC: 10576558. DOI: 10.3389/fnagi.2023.1265151.